EMERGENT BIOSOLUTIONS INC. (EBS) Gross margin 2016–2025
EMERGENT BIOSOLUTIONS INC. (EBS) gross margin by fiscal year — reported gross profit divided by reported revenue.
56.1%FY2025 · since FY2016: 74.2% → 56.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 56.1% | +21.4 pp |
| FY2024 | 34.7% | +4.4 pp |
| FY2023 | 30.3% | -4.0 pp |
| FY2022 | 34.3% | -16.0 pp |
| FY2021 | 50.3% | -9.2 pp |
| FY2020 | 59.5% | -1.3 pp |
| FY2019 | 60.8% | +2.0 pp |
| FY2018 | 58.8% | -7.7 pp |
| FY2017 | 66.5% | -7.6 pp |
| FY2016 | 74.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice